Bonnie Yates

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Terry J. Fry, Nirali N. Shah, Rimas J. Orentas et al. · Nature Medicine · 2017 · 1.3K citations · Full text

Allergy, Autoimmune Disease, Cd19-targeted Car Immunotherapy +9

CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

Nirali N. Shah, Steven L. Highfill, Haneen Shalabi et al. · Journal of Clinical Oncology · 2020 · 400 citations · Full text

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

Nirali N. Shah, Daniel W. Lee, Bonnie Yates et al. · Journal of Clinical Oncology · 2021 · 344 citations · Full text

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

Daniel A. Lichtenstein, Fiorella Schischlik, Lipei Shao et al. · Blood · 2021 · 173 citations · Full text

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Haneen Shalabi, Haiying Qin, Angela Su et al. · Blood · 2022 · 164 citations · Full text